Business ❯Healthcare ❯Pharmaceuticals

Acquisitions

Organon-Dermavant Johnson & Johnson Merck KGaA AstraZeneca

SpringWorks Shares Surge on Reported Acquisition Talks with Merck KGaA

Johnson & Johnson to Acquire Intra-Cellular Therapies in $14.6 Billion Deal

Organon Acquires Dermavant from Roivant for Up to $1.2 Billion

AstraZeneca Acquires Fusion Pharmaceuticals in $2.4 Billion Deal to Boost Cancer Treatment Pipeline